Literature DB >> 23150424

An investigation of risk factors for renal cell carcinoma by histologic subtype in two case-control studies.

Mark P Purdue1, Lee E Moore, Maria J Merino, Paolo Boffetta, Joanne S Colt, Kendra L Schwartz, Vladimir Bencko, Faith G Davis, Barry I Graubard, Vladimir Janout, Julie J Ruterbusch, Jennifer Beebe-Dimmer, Michele L Cote, Brian Shuch, Dana Mates, Jonathan N Hofmann, Lenka Foretova, Nathaniel Rothman, Neonilia Szeszenia-Dabrowska, Vsevolod Matveev, Sholom Wacholder, David Zaridze, W Marston Linehan, Paul Brennan, Wong-Ho Chow.   

Abstract

To investigate whether renal cell carcinoma (RCC) histologic subtypes possess different etiologies, we conducted analyses of established RCC risk factors by subtype (clear cell, papillary and chromophobe) in two case-control studies conducted in the United States (1,217 cases, 1,235 controls) and Europe (1,097 cases, 1,476 controls). Histology was ascertained for 706 U.S. cases (58% of total) and 917 European cases (84%) through a central slide review conducted by a single pathologist. For the remaining cases, histology was abstracted from the original diagnostic pathology report. Case-only analyses were performed to compute odds ratios (ORs) and 95% confidence intervals (CI) summarizing subtype differences by age, sex and race. Case-control analyses were performed to compute subtype-specific ORs for other risk factors using polytomous regression. In case-only analyses, papillary cases (N = 237) were older (OR = 1.2, 95% CI = 1.1-1.4 per 10-year increase), less likely to be female (OR = 0.5, 95% CI = 0.4-0.8) and more likely to be black (OR = 2.6, 95% CI = 1.8-3.9) as compared to clear cell cases (N = 1,524). In case-control analyses, BMI was associated with clear cell (OR = 1.2, 95% CI = 1.1-1.3 per 5 kg/m(2) increase) and chromophobe RCC (N = 80; OR = 1.2, 95% CI = 1.1-1.4), but not papillary RCC (OR = 1.1, 95% CI = 1.0-1.2; test versus clear cell, p = 0.006). No subtype differences were observed for associations with smoking, hypertension or family history of kidney cancer. Our findings support the existence of distinct age, sex and racial distributions for RCC subtypes, and suggest that the obesity-RCC association differs by histology.
Copyright © 2013 UICC.

Entities:  

Mesh:

Year:  2013        PMID: 23150424      PMCID: PMC3717609          DOI: 10.1002/ijc.27934

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  35 in total

1.  Family history and the risk of kidney cancer: a multicenter case-control study in Central Europe.

Authors:  Rayjean J Hung; Lee Moore; Paolo Boffetta; Bing-Jian Feng; Jorge R Toro; Nathanial Rothman; David Zaridze; Marie Navratilova; Vladimir Bencko; Vladimir Janout; Helena Kollarova; Neonila Szeszenia-Dabrowska; Dana Mates; Wong-Ho Chow; Paul Brennan
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2007-06       Impact factor: 4.254

2.  Chromophobe renal cell carcinoma in Iceland: an epidemiological and clinicopathological study.

Authors:  Johann P Ingimarsson; Sverrir Hardarson; Vigdis Petursdottir; Eirikur Jonsson; Gudmundur V Einarsson; Tomas Gudbjartsson
Journal:  Scand J Urol Nephrol       Date:  2011-05-27

3.  Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas.

Authors:  L Schmidt; F M Duh; F Chen; T Kishida; G Glenn; P Choyke; S W Scherer; Z Zhuang; I Lubensky; M Dean; R Allikmets; A Chidambaram; U R Bergerheim; J T Feltis; C Casadevall; A Zamarron; M Bernues; S Richard; C J Lips; M M Walther; L C Tsui; L Geil; M L Orcutt; T Stackhouse; J Lipan; L Slife; H Brauch; J Decker; G Niehans; M D Hughson; H Moch; S Storkel; M I Lerman; W M Linehan; B Zbar
Journal:  Nat Genet       Date:  1997-05       Impact factor: 38.330

4.  Statistical analysis of molecular epidemiology studies employing case-series.

Authors:  C B Begg; Z F Zhang
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1994-03       Impact factor: 4.254

5.  Rate of renal cell carcinoma subtypes in different races.

Authors:  Alexander Sankin; Jacob Cohen; Hongbei Wang; Richard J Macchia; Nicholas Karanikolas
Journal:  Int Braz J Urol       Date:  2011 Jan-Feb       Impact factor: 1.541

6.  Clinicopathologic features of renal cell carcinoma in young adults: a comparison study with renal cell carcinoma in older patients.

Authors:  Jae Hee Suh; Tina Oak; Jae Y Ro; Luan D Truong; Alberto G Ayala; Steven S Shen
Journal:  Int J Clin Exp Pathol       Date:  2009-01-30

7.  Improved identification of von Hippel-Lindau gene alterations in clear cell renal tumors.

Authors:  Michael L Nickerson; Erich Jaeger; Yangu Shi; Jeffrey A Durocher; Sunil Mahurkar; David Zaridze; Vsevolod Matveev; Vladimir Janout; Hellena Kollarova; Vladimir Bencko; Marie Navratilova; Neonilia Szeszenia-Dabrowska; Dana Mates; Anush Mukeria; Ivana Holcatova; Laura S Schmidt; Jorge R Toro; Sara Karami; Rayjean Hung; Gary F Gerard; W Marston Linehan; Maria Merino; Berton Zbar; Paolo Boffetta; Paul Brennan; Nathaniel Rothman; Wong-Ho Chow; Frederic M Waldman; Lee E Moore
Journal:  Clin Cancer Res       Date:  2008-08-01       Impact factor: 12.531

8.  Family history of cancer and renal cell cancer risk in Caucasians and African Americans.

Authors:  S Karami; K Schwartz; M P Purdue; F G Davis; J J Ruterbusch; S S Munuo; S Wacholder; B I Graubard; J S Colt; W-H Chow
Journal:  Br J Cancer       Date:  2010-05-04       Impact factor: 7.640

9.  DNA base modifications in renal chromatin of Wistar rats treated with a renal carcinogen, ferric nitrilotriacetate.

Authors:  S Toyokuni; T Mori; M Dizdaroglu
Journal:  Int J Cancer       Date:  1994-04-01       Impact factor: 7.396

10.  The VHL tumor suppressor inhibits expression of the IGF1R and its loss induces IGF1R upregulation in human clear cell renal carcinoma.

Authors:  J S P Yuen; M E Cockman; M Sullivan; A Protheroe; G D H Turner; I S Roberts; C W Pugh; H Werner; V M Macaulay
Journal:  Oncogene       Date:  2007-05-07       Impact factor: 9.867

View more
  28 in total

1.  Vitamin C's essential role in DNA and histone demethylation and a preclinical rationale for its therapeutic high-dose potential in renal cell carcinoma.

Authors:  Ching-Hui Huang; Chia-Chu Chang
Journal:  Ann Transl Med       Date:  2019-07

2.  Obesity and renal cell carcinoma risk by histologic subtype: A nested case-control study and meta-analysis.

Authors:  Catherine L Callahan; Jonathan N Hofmann; Douglas A Corley; Wei K Zhao; Brian Shuch; Wong-Ho Chow; Mark P Purdue
Journal:  Cancer Epidemiol       Date:  2018-07-18       Impact factor: 2.984

3.  Mitochondrial DNA copy number in peripheral blood leukocytes and the risk of clear cell renal cell carcinoma.

Authors:  Stephanie C Melkonian; Xin Wang; Jian Gu; Surena F Matin; Nizar M Tannir; Christopher G Wood; Xifeng Wu
Journal:  Carcinogenesis       Date:  2014-12-18       Impact factor: 4.944

4.  Race effects on pathological and functional outcomes after robotic partial nephrectomy in a single academic tertiary care center.

Authors:  Onder Kara; Hiury S Andrade; Homayoun Zargar; Oktay Akca; Matthew J Maurice; Peter A Caputo; Daniel Ramirez; Ercan Malkoc; Charles S Modlin; Jihad H Kaouk
Journal:  J Robot Surg       Date:  2016-02-09

5.  Antihypertensive medication use and risk of renal cell carcinoma.

Authors:  Joanne S Colt; Jonathan N Hofmann; Kendra Schwartz; Wong-Ho Chow; Barry I Graubard; Faith Davis; Julie Ruterbusch; Sonja Berndt; Mark P Purdue
Journal:  Cancer Causes Control       Date:  2017-02-21       Impact factor: 2.506

6.  Prognostic significance of promoter CpG island methylation of obesity-related genes in patients with nonmetastatic renal cell carcinoma.

Authors:  Julia Mendoza-Pérez; Jian Gu; Luis A Herrera; Nizar M Tannir; Shanyu Zhang; Surena Matin; Jose A Karam; Christopher G Wood; Xifeng Wu
Journal:  Cancer       Date:  2017-05-23       Impact factor: 6.860

7.  Evidence for aldosterone-dependent growth of renal cell carcinoma.

Authors:  Sharon King; Susan Bray; Sarah Galbraith; Lesley Christie; Stewart Fleming
Journal:  Int J Exp Pathol       Date:  2014-05-07       Impact factor: 1.925

8.  Genomic DNA Hypomethylation and Risk of Renal Cell Carcinoma: A Case-Control Study.

Authors:  Julia Mendoza-Pérez; Jian Gu; Luis A Herrera; Nizar M Tannir; Surena F Matin; Jose A Karam; Maosheng Huang; David W Chang; Christopher G Wood; Xifeng Wu
Journal:  Clin Cancer Res       Date:  2015-12-11       Impact factor: 12.531

9.  Understanding racial disparities in renal cell carcinoma incidence: estimates of population attributable risk in two US populations.

Authors:  Catherine L Callahan; Kendra Schwartz; Douglas A Corley; Julie J Ruterbusch; Wei K Zhao; Brian Shuch; Barry I Graubard; Nathaniel Rothman; Wong-Ho Chow; Debra T Silverman; Mark P Purdue; Jonathan N Hofmann
Journal:  Cancer Causes Control       Date:  2019-11-28       Impact factor: 2.506

10.  Analgesic use and risk of renal cell carcinoma: A case-control, cohort and meta-analytic assessment.

Authors:  Sara Karami; Sarah E Daughtery; Kendra Schwartz; Faith G Davis; Julie J Ruterbusch; Sholom Wacholder; Barry I Graubard; Sonja I Berndt; Jonathan N Hofmann; Mark P Purdue; Lee E Moore; Joanne S Colt
Journal:  Int J Cancer       Date:  2016-04-09       Impact factor: 7.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.